Status:
UNKNOWN
A Study of Factor Inhibitors in Adult Patients With Hemophilia and Von Willebrand's Disease in Upper Egypt
Lead Sponsor:
Safaa AA Khaled
Conditions:
Hemophilia
Von Willebrand Diseases
Eligibility:
All Genders
18-55 years
Brief Summary
Hemophilia A and B are bleeding disorders caused by deficiency of factor VIII and IX, respectively. The deficiency of one of these coagulation factors is due to a mutation on the X chromosome. Accordi...
Detailed Description
Individuals with hemophilia are deficient in one of the clotting factor proteins that are vital in the formation of a clot. Classic hemophilia or hemophilia A is a deficiency of factor VIII, while Chr...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients diagnosed congenital hemophilia A, Christmas disease, and VWD
- Exclusion Criteria
- Patients diagnosed with acquired hemophilia
- Patients below 18 years
- Patients with other bleeding tendencies
Exclusion
Key Trial Info
Start Date :
May 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 20 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04106323
Start Date
May 10 2020
End Date
August 20 2021
Last Update
March 12 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.